NR607 Standardized Procedure Worksheet
Name: Sansita Bhatta
Carefully read the assignment guidelines and rubric and complete each section of the worksheet below.
1. Definition
a. Disease or
condition Serotonin
Syndrome
b. Pathophysiology
Serotonin syndrome is a potentially life-threatening condition resulting from
an excess of serotonin in the central nervous system. The pathophysiology of
serotonin syndrome primarily involves an overactivity of serotonin (5-HT) in
the central nervous system (CNS) and peripheral serotonin receptors (Badar,
2024). This overactivity typically results from therapeutic drug use,
intentional self-poisoning, or inadvertent drug interactions.
In serotonin syndrome, excessive serotonin accumulation in the CNS leads to
overstimulation of these receptors. This can occur through increased
serotonin production (e.g., L-tryptophan), release (e.g., amphetamines),
inhibition of reuptake (e.g., SSRIs, SNRIs), or inhibition of breakdown (e.g.,
MAOIs) (Badar, 2024). The overstimulation of serotonin receptors results in
the varied symptoms of serotonin syndrome.
c. Incidence and prevalence
The true incidence of serotonin syndrome (SS) is unknown and likely
underreported, with symptoms often resembling other conditions and mild
cases frequently missed. The rise in Serotonin Syndrome cases is attributed to
the increased use of serotonergic drugs, especially SSRIs. The Toxic Exposure
Surveillance System recorded 54,410 SSRI poisoning cases in 2016, with 102
deaths, estimating that about 15% of these may be Serotonin Syndrome
(Mikkelsen et al., 2023). Another US dataset suggests an SS incidence of
0.07% to 0.19% (Mikkelsen et al., 2023). However, with the increasing use of
serotonergic drugs, the prevalence is believed to be rising and more
commonly seen in individuals taking multiple serotonergic medications
(Prakash et al., 2021). It’s generally believed that the condition is relatively
rare.
About 15% of SSRI overdoses result in mild to moderate SS, while severe
cases are rare (Chiew & Isbister, 2024). Co-ingestion of moclobemide
, increases SS risk, whereas
0320 RB/KK
Name: Sansita Bhatta
Carefully read the assignment guidelines and rubric and complete each section of the worksheet below.
1. Definition
a. Disease or
condition Serotonin
Syndrome
b. Pathophysiology
Serotonin syndrome is a potentially life-threatening condition resulting from
an excess of serotonin in the central nervous system. The pathophysiology of
serotonin syndrome primarily involves an overactivity of serotonin (5-HT) in
the central nervous system (CNS) and peripheral serotonin receptors (Badar,
2024). This overactivity typically results from therapeutic drug use,
intentional self-poisoning, or inadvertent drug interactions.
In serotonin syndrome, excessive serotonin accumulation in the CNS leads to
overstimulation of these receptors. This can occur through increased
serotonin production (e.g., L-tryptophan), release (e.g., amphetamines),
inhibition of reuptake (e.g., SSRIs, SNRIs), or inhibition of breakdown (e.g.,
MAOIs) (Badar, 2024). The overstimulation of serotonin receptors results in
the varied symptoms of serotonin syndrome.
c. Incidence and prevalence
The true incidence of serotonin syndrome (SS) is unknown and likely
underreported, with symptoms often resembling other conditions and mild
cases frequently missed. The rise in Serotonin Syndrome cases is attributed to
the increased use of serotonergic drugs, especially SSRIs. The Toxic Exposure
Surveillance System recorded 54,410 SSRI poisoning cases in 2016, with 102
deaths, estimating that about 15% of these may be Serotonin Syndrome
(Mikkelsen et al., 2023). Another US dataset suggests an SS incidence of
0.07% to 0.19% (Mikkelsen et al., 2023). However, with the increasing use of
serotonergic drugs, the prevalence is believed to be rising and more
commonly seen in individuals taking multiple serotonergic medications
(Prakash et al., 2021). It’s generally believed that the condition is relatively
rare.
About 15% of SSRI overdoses result in mild to moderate SS, while severe
cases are rare (Chiew & Isbister, 2024). Co-ingestion of moclobemide
, increases SS risk, whereas
0320 RB/KK
